Remove Doctors Remove Drug Trials Remove Drugs Remove Vaccination
article thumbnail

Scepticism in press over Kintor’s COVID-19 US drug trial

pharmaphorum

China’s Kintor Pharmaceutical has begun late-stage US clinical development of its potential COVID drug proxalutamide – but there is scepticism over the company’s claims about its research. But Reuters reported that the doctor identified as its principal clinical trial investigator has said he is not in charge of the trial.

article thumbnail

HCP’s use of social media: the good and the not so good

World of DTC Marketing

Doximity was flagged for having anti-vaccine information. The best approach is to use social media to connect HCPs to clincial information and drug trials. A leading pharma company recently sponsored a series of Q&A around the use of their new cancer drug. Most said it had, but they still wanted to know more.

Nurses 294
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Phases of Clinical Research: A Detailed Overview

Advarra

Clinical trials are studies involving human volunteers to research ways to prevent, detect, and treat various medical conditions. The goal is to identify safer, more effective methods of treating illnesses using new drugs or new combinations of existing drugs.

article thumbnail

Steps to building a more patient-centric industry

pharmaphorum

According to the FDA’s 2020 Drug Trials Snapshot Report , only 8% of clinical trial participants are Black or African American, as compared to nearly 14% of the US population. The fact is, many minorities never learn about vital clinical trials in play, or that they’re eligible to participate. Keep it simple.

article thumbnail

Why Black People Remain Underrepresented in Clinical Trials

XTalks

Despite these statistics, in the US, Black people only constitute five percent of all clinical trial participants. The overwhelming majority of trial participants nationwide are white. Educating potential Black trial participants about different trial models could help encourage greater participation.

article thumbnail

Advancement through adversity: how Covid-driven innovations are becoming best practices for pharmacovigilance

Pharmaceutical Technology

Pharmacovigilance refers to the practice of collecting, detecting, assessing, monitoring and preventing adverse effects (AEs) caused by new drug substances. After AEs are recorded, they must be translated and put back out to doctors and scientists for processing. Adapting pharmacovigilance to deal with surging case reports.

Engineer 130